價(jià)格 | ¥247 | ¥538 | ¥868 |
包裝 | 1mg | 5mg | 10mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 BRD4770 | 英文名稱:BRD4770 |
CAS:1374601-40-7 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 99.82% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T1923 |
名稱 | BRD4770 |
描述 | BRD4770 is a histone methyltransferase G9a inhibitor and induces cell senescence. |
細(xì)胞實(shí)驗(yàn) | PANC-1 cells are seeded and treated with BRD4770 in 6-well plates for 72 h. Cells are trypsinized and tested for soft agar colony formation using CytoSelect 96-Well Cell Transformation Assay, using the CyQuant GR dye to measure total cellular nucleic acid levels. Fluorescence is detected with an Analyst HT plate reader using a 485/520 nm filter set.(Only for Reference) |
激酶實(shí)驗(yàn) | Biochemical activity of G9a: Dissociation Enhanced Lanthanide Fluoro-ImmunoAssays (DELFIA) are performed in white, opaque 384-well plates coated with Neutravidin. Test compounds are diluted to 12 μg/mL in 50 mM Tris-HCl pH 8.5 containing 4% DMSO and 10 μL is dispensed into the wells. Blank and control wells received only compound buffer. GST-G9a at 10 μg/mL and SAM at 40 μM are diluted in 50 mM Tris HCl pH 8.5/10 mM DTT and added in a volume of 20 μL. Blank wells receives Tris/DTT buffer only. The reactions are initiated by the addition of 800 nM H3(1-20)-cysbiotin substrate in 50 mM Tris pH 8.5 in a volume of 10 μl, and incubated at room temperature for 60 minutes. The plates are washed 3 times with 100 μl of Wash Buffer (50 mM Tris pH 7.4, 150 mM NaCl, 0.05% Tween 20, 0.2% BSA). Next, 50 μl of Fluoroimmunoassay (FI) Buffer (50 mM Tris HCl pH 7.8, 150 mM NaCl, 0.05% Tween 40, 25 μM DTPA, 0.2% BSA, 0.05% BGG) containing 5ng α-2X-di-meth H3-K9 and 5ng goat anti-rabbit Eu chelate is added to all wells of the plate, and the plate is incubated for an additional hour at room temperature. The plates are washed 3 times with 100 μL of Wash Buffer, and 50 μL of Enhancement Solution is added to each well. Time resolved fluorescence is measured after 45 minutes on a Viewlux Microplate Imager imaging for 15 seconds with a 354 μs window, 400 μs delay, excitation at 360 nm, and emission at 618 nm. |
體內(nèi)活性 | BRD4770和棉酚聯(lián)用可以增加LC3-II水平和自噬體數(shù)量,從而協(xié)同作用誘導(dǎo)PANC-1細(xì)胞死亡。BRD4770在胰腺癌細(xì)胞系PANC-1中,通過(guò)通過(guò)抑制G9a降低二 - 和三甲基化H3K9的細(xì)胞水平,誘導(dǎo)衰老,并抑制貼壁依賴性和非依賴性增殖。 |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 8.3 mg/mL (20 mM) |
關(guān)鍵字 | EHMT2 | G9a | Histone Methyltransferase | BRD4770 | H3K9 | cell-permeable | ATR | chromatin | anti-proliferation | methylation | BRD-4770 | Inhibitor | ATM | senescent | inhibit | BRD 4770 |
相關(guān)產(chǎn)品 | Tazemetostat hydrobromide | XY1 | MRTX-1719 | MAK683 | Tazemetostat | iso-Azalansta | EPZ015666 | UNC 0631 | AMI-1 free acid | MS37452 | MAK-683 hydrochloride | Piribedil |
相關(guān)庫(kù) | 抑制劑庫(kù) | 經(jīng)典已知活性庫(kù) | 已知活性化合物庫(kù) | 組蛋白修飾化合物庫(kù) | NO PAINS 化合物庫(kù) | 干細(xì)胞分化化合物庫(kù) | 表觀遺傳庫(kù) | 抗COVID-19化合物庫(kù) | 表型篩選靶點(diǎn)鑒定庫(kù) | 細(xì)胞重編程化合物庫(kù) |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2025-01-19 | |
詢價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
¥198 |
VIP12年
|
上海陶術(shù)生物科技有限公司
|
2024-12-02 | |
詢價(jià) |
VIP6年
|
上海澤葉生物科技有限公司
|
2025-01-20 | |
¥926.90 |
VIP2年
|
上海阿拉丁生化科技股份有限公司
|
2024-11-29 |